15353-j-veluchamy

5 Towards UCB-NK cells treatment in colorectal cancer | 139 Supplementary figure 1: Expression profiles of NK cell receptors in CRC patients Resting NK cells within PBMC populations from healthy controls and from mCRC patients at baseline and after 1 cycle of chemotherapy were monitored for the NK activating receptors NKG2D (A), NKG2C (B) and NK inhibitory receptors NKG2A (C) and KIR2D (D). Data represent mean ± SEM from 10 mCRC patients and 10 healthy controls. Statistical difference was calculated with one-way ANOVA, multiple comparison between column means.